Lineage Cell Therapeutics, Inc. (LCTX) Net income 2016–2025
Lineage Cell Therapeutics, Inc. (LCTX) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$63.5MFY2025 · since FY2016: $33.6M → -$63.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$63.5M | -241.4% |
| FY2024 | -$18.6M | +13.4% |
| FY2023 | -$21.5M | +18.2% |
| FY2022 | -$26.3M | +38.9% |
| FY2021 | -$43.0M | -108.3% |
| FY2020 | -$20.6M | -76.4% |
| FY2019 | -$11.7M | +74.5% |
| FY2018 | -$46.0M | -130.2% |
| FY2017 | -$20.0M | -159.5% |
| FY2016 | $33.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice